Enbrel
Sponsors
National Eye Institute (NEI), The University of Texas Health Science Center at San Antonio, Amgen, The Cleveland Clinic, Wyeth is now a wholly owned subsidiary of Pfizer
Conditions
Ankylosing SpondylitisArthritis, RheumatoidAxial SpondyloarthritisBone CancerChronic Stable Plaque PsoriasisHealthyJuvenile Rheumatoid ArthritisLung Cancer
Phase 1
Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®
CompletedNCT01145950
Start: 2010-06-30End: 2011-01-31Target: 36Updated: 2011-02-18
Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)
TerminatedNCT02481180
Start: 2015-07-31End: 2017-11-06Updated: 2019-07-08
Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis
NCT04559412
Start: 2021-03-15End: 2024-12-31Updated: 2023-04-12
Phase 2
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
CompletedNCT00001862
Start: 1999-02-28End: 2003-03-31Target: 15Updated: 2008-03-04
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
TerminatedNCT00127387
Start: 2001-05-31End: 2005-11-30Target: 54Updated: 2012-06-26
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
CompletedNCT00224393
Start: 2001-02-28End: 2005-08-31Target: 60Updated: 2023-05-30
Phase 3
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel
CompletedNCT01891864
Start: 2013-06-30End: 2015-03-31Updated: 2017-03-27
A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT02357069
Start: 2015-02-28Target: 372Updated: 2016-01-06
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
NCT04079374
Start: 2018-09-03End: 2023-12-03Target: 160Updated: 2021-02-03
Phase 4
Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
CompletedNCT00132418
Start: 2000-04-30End: 2004-02-29Updated: 2011-01-21
Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
CompletedNCT01934933
Start: 2014-09-24End: 2017-01-30Updated: 2018-06-18
Unknown Phase
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
CompletedNCT00245934
Start: 2003-06-30End: 2005-07-31Target: 1500Updated: 2007-12-14
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
CompletedNCT01188655
Start: 2008-05-31End: 2010-03-31Updated: 2011-09-12
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
TerminatedNCT01411215
Start: 2011-01-31End: 2013-01-31Updated: 2014-03-06
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
CompletedNCT01421303
Start: 2009-10-31End: 2013-12-31Updated: 2014-12-12
Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel
CompletedNCT03100734
Start: 2017-06-01End: 2018-11-30Updated: 2021-02-05
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
CompletedNCT04398732
Start: 2020-07-05End: 2020-10-01Updated: 2021-11-01
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
CompletedNCT04428424
Start: 2020-07-05End: 2020-08-30Updated: 2021-09-09
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
CompletedNCT04428502
Start: 2020-07-05End: 2020-08-30Updated: 2021-09-14
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
CompletedNCT04428411
Start: 2020-07-05End: 2020-08-30Updated: 2021-10-25